Oatly outlines 2025 profit growth targets with 2%-4% revenue increase and $5M-$15M EBITDA goal Seeking Alpha / 17 hours ago 1 Views Read more
DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development Seeking Alpha / - 10 minutes ago
HOME VALUES IN OPPORTUNITY ZONES CONTINUE TO RIDE COATTAILS OF NATIONAL GAINS DURING FOURTH QUARTER Seeking Alpha / - 49 minutes ago
BENDING THE ADOPTION CURVE: NEXT-GEN MATERIALS TO REACH 8% OF FIBER MARKET BY 2030 Seeking Alpha / - 49 minutes ago
Woolpert Welcomes Head of Strategic Growth, Asia-Pacific Susie Henderson Seeking Alpha / - 51 minutes ago
Comments